Reviewed by Dr. Mark A. Cappel, MD, Double Board-Certified Dermatologist and Dermatopathologist, Founder of Dermagnify | Ponte Vedra Beach, FL
It is one of the most common questions I hear from patients during a first rosacea consultation: if I just take care of my skin and avoid my triggers, will this eventually clear up on its own?
The honest answer, and the one that matters most for long-term skin health, is this: for the vast majority of patients, rosacea does not resolve spontaneously. It is a chronic, progressive condition. Without appropriate treatment, it tends to worsen over years rather than improve. The flare-and-calm pattern that many patients experience can create a misleading impression that the condition is improving between flares. It is not. The underlying vascular and inflammatory changes continue to accumulate beneath the surface.
Understanding this progression is not meant to alarm you. It is meant to give you an accurate picture so you can make informed decisions about when to seek treatment and which approach addresses the condition at its source rather than just managing symptoms when they become visible.
What Rosacea Is Doing Beneath the Surface
Rosacea is not a surface problem. It is a chronic inflammatory and vascular condition that originates in the neurovascular biology of the facial skin. Patients with rosacea have blood vessels that dilate too readily in response to triggers, and an immune system that over-responds to stimuli that healthy skin ignores. The result is persistent, low-grade inflammation that causes damage to the structural support of facial skin even when the skin appears relatively calm.
The structural changes that accumulate over time include:
- Permanent vasodilation - Blood vessels that repeatedly dilate in response to triggers gradually lose their elasticity and remain in a state of chronic dilation, creating the fixed redness that does not resolve between flares
- Telangiectasia - Visibly dilated capillaries that appear as fine red lines on the cheeks, nose, and chin. These represent permanent vascular damage that does not reverse on its own
- Dermal thickening - In advanced rosacea, the skin can develop a rough, thickened texture. The most recognized form is rhinophyma, a bulbous thickening of the nose
- Neural sensitization - The facial nervous system becomes progressively more reactive over time, lowering the threshold for flushing and irritation in response to increasingly minor stimuli
The Four Subtypes and How They Progress
Rosacea is classified into four primary subtypes, each with a distinct presentation and progressive trajectory. While not all patients follow a linear progression through every subtype, research suggests that untreated rosacea in many patients advances from milder to more severe presentations over time.
| Subtype | Clinical Features | Progression Without Treatment |
|---|---|---|
| Erythematotelangiectatic (ETR) | Flushing, persistent redness, visible blood vessels | Redness becomes fixed; telangiectasia multiplies; flushing threshold lowers progressively |
| Papulopustular | Redness with acne-like bumps and pustules | Lesions become more frequent and slower to resolve; baseline inflammation increases |
| Phymatous | Skin thickening, irregular texture, rhinophyma | Tissue overgrowth is largely irreversible without intervention; worsens significantly over time |
| Ocular | Eye redness, irritation, dryness, lid inflammation | Can progress to corneal involvement if untreated; does not spontaneously resolve |
Not every patient progresses through all four subtypes, and severity varies widely by individual. However, the clinical consensus is that untreated rosacea rarely improves over time. The redness that was intermittent at 30 is often fixed by 45. The broken capillaries that appeared in one area spread to adjacent areas. The skin that flushed in response to wine and heat begins flushing in response to warmth, stress, and even minor temperature changes.
Does Rosacea Get Worse With Age?
For most patients, yes. This is not inevitable, but it is the most common clinical trajectory when the condition is not actively managed.
The first reason is cumulative trigger exposure. Each flare sensitizes the vascular and neural systems slightly, making the next flare more easily triggered and more intense. The condition does not reset between flares; it accumulates.
The second reason is normal aging. Collagen loss reduces the structural support of the skin, making the vascular changes beneath the surface increasingly visible. A network of dilated capillaries that was partly hidden beneath healthy collagen at 35 becomes prominently visible as skin thins and loses firmness at 55.
A 2013 cross-sectional survey published in the British Journal of Dermatology examined rosacea patients and found evidence suggestive of progression between subtypes over time, with some patients appearing to move from early redness and flushing toward more persistent features like visible blood vessels and, later, thickening of the skin. The researchers were careful to note the evidence was preliminary, but the pattern reinforces a practical point: rosacea often doesn't stay still, which is why early, consistent management matters.
Does Rosacea Come and Go?
Yes, and this pattern is one of the most clinically significant misunderstandings about the condition. Rosacea does flare and calm in response to triggers and seasons. Many patients experience relatively clear periods between flares, which creates a reasonable but inaccurate impression that the condition may be resolving.
What is actually happening during a calm period is that the surface inflammation has temporarily quieted while the underlying vascular and structural changes continue to develop. Each cycle of flaring and calming tends to leave the baseline state slightly more inflamed than before. Periods of apparent improvement should not delay treatment decisions.
Why Avoiding Triggers Is Not Enough
Trigger avoidance is a reasonable and necessary part of rosacea management. Reducing UV exposure, moderating alcohol intake, and using gentle skincare products all reduce the frequency and intensity of flares. But trigger avoidance addresses symptom precipitation, not the underlying condition.
The vascular abnormalities that cause rosacea, including the overactive dilatory response of facial blood vessels and the chronic low-grade inflammatory state of the perivasicular tissue, are not resolved by avoiding the stimuli that make them more visible. Similarly, topical medications including metronidazole, azelaic acid, and ivermectin reduce the pustular and inflammatory component effectively but do not address the vascular abnormalities that drive erythema and telangiectasia.
How Aerolase Laser Treatment Changes the Picture
The most clinically significant advance in rosacea treatment is the development of vascular-targeting laser technology. Unlike topicals and trigger avoidance, laser treatment addresses the underlying vascular architecture responsible for rosacea's chronic progression.
At Dermagnify, we use the Aerolase Neo, a 1064nm Nd:YAG laser with a proprietary 650-microsecond pulse duration uniquely suited for rosacea treatment.
Targeting Dilated Blood Vessels
The 1064nm wavelength is selectively absorbed by oxyhemoglobin in the dilated blood vessels responsible for rosacea's visible redness and telangiectasia. The laser energy heats and coagulates these vessels, which are then absorbed by the body's lymphatic system. Over a series of sessions, the density of the vascular network responsible for rosacea's redness is reduced, producing improvements that trigger avoidance and topicals cannot replicate.
The 650-Microsecond Pulse: Why It Matters
The Aerolase's 650-microsecond pulse technology delivers sufficient energy to coagulate target vessels while minimizing heat spread to surrounding tissue. The result is a no-downtime, pain-free treatment that is safe for all skin types, including patients with darker skin tones who cannot safely undergo many traditional rosacea laser treatments.
Reducing Inflammatory Load
Beyond direct vascular targeting, the Aerolase Neo reduces the chronic perivasicular inflammation that drives rosacea's progressive nature. By interrupting the inflammatory cycle at its vascular source rather than at the surface, laser treatment addresses the root pathophysiology in a way that no topical or systemic medication does.
Learn more about the Aerolase Neo for rosacea at Dermagnify, or see the full Aerolase laser overview.
What About Other Aerolase Platforms?
While the Aerolase Neo is the primary platform for rosacea's vascular and inflammatory components, patients with rosacea-associated skin changes may benefit from complementary treatments:
- Aerolase Era: for patients with rosacea-related textural changes or acne-like scarring. The Era's ablative fractional capability improves skin texture and surface irregularities that develop in papulopustular and phymatous rosacea over time
- Aerolase Reverse: for patients who develop post-inflammatory hyperpigmentation or pigmentation changes that compound the redness and uneven tone associated with rosacea
How Many Sessions and When to Start
For most patients, an initial series of 3 to 5 Aerolase Neo sessions spaced 3 to 4 weeks apart produces meaningful reduction in redness, visible blood vessels, and inflammatory burden. Maintenance sessions every 6 to 12 months help prevent progressive accumulation.
Earlier treatment produces better outcomes. Laser treatment addresses vessels and inflammatory tissue that are present. It cannot restore the collagen and dermal structure already lost to years of untreated progression, and it cannot fully reverse phymatous changes that have developed over decades.
If your rosacea has been present for years and you have been managing it with avoidance and topicals alone, it is not too late to benefit from laser treatment. But the sooner it begins, the less structural damage has accumulated and the more the laser has to work with.
What to Expect at Dermagnify
At Dermagnify in Ponte Vedra Beach, Florida, rosacea consultations begin with a comprehensive clinical assessment by Dr. Mark A. Cappel, MD, a double board-certified dermatologist and dermatopathologist. This includes a detailed review of your rosacea history, subtype classification, trigger mapping, and an evaluation using Alma IQ advanced imaging.
The Aerolase Neo treatment takes approximately 15 to 30 minutes for a full face. No numbing cream is required for most patients. There is no downtime. Visible improvement in redness and flushing is often noticeable within the first 24 to 48 hours.
Read more about rosacea and redness at Dermagnify for a detailed overview of the condition, triggers, and the full range of treatment options we offer.
Dermagnify serves patients from Ponte Vedra Beach, Jacksonville, Jacksonville Beach, Atlantic Beach, St. Augustine, and throughout St. Johns, Duval, Clay, and Nassau counties.
Ready to Discuss Your Rosacea With Dr. Cappel?
Ready to start? Book a rosacea consultation at Dermagnify in Ponte Vedra Beach, FL. Dr. Cappel will assess your rosacea subtype, progression, and treatment history, and design a personalized protocol with Aerolase laser.
Frequently Asked Questions
Can rosacea be cured?
There is currently no permanent cure for rosacea. However, with consistent management including trigger avoidance, prescription therapy, and vascular-targeting laser treatment, rosacea can be brought to a state where it causes minimal visible impact on daily life. Many patients who maintain regular Aerolase treatment are functionally clear between sessions. Durable, well-managed remission is the realistic and achievable goal.
Will my rosacea definitely get worse if I do not treat it?
Not necessarily in every patient. A small subset of patients experience stable, mild rosacea for many years. However, clinical data consistently shows that untreated rosacea progresses in the majority of cases. The specific rate depends on your subtype, individual inflammatory response, and trigger exposure. Assuming stability without treatment is not a clinically justified assumption for most patients.
How long does it take for Aerolase to improve rosacea?
Most patients notice initial improvement in redness and flushing within 2 to 4 weeks after their first session. More significant and lasting improvement develops over the full initial treatment series of 3 to 5 sessions. The cumulative effect continues to develop over 3 to 4 months following the completion of the initial series.
Is Aerolase safe for sensitive, rosacea-prone skin?
Yes. The Aerolase Neo's 650-microsecond pulse technology was specifically developed to be gentle enough for highly reactive skin. It requires no numbing cream for most patients, produces no significant post-procedure inflammation, and has no downtime. It is safe for all Fitzpatrick skin types, including darker complexions that are not candidates for many other rosacea laser treatments.
Can rosacea affect my eyes?
Yes. Ocular rosacea affects the eyes and eyelids, causing redness, irritation, and dryness. It is estimated to affect up to 50% of rosacea patients to some degree. Ocular rosacea does not resolve without treatment and requires coordinated management with an ophthalmologist in addition to dermatologic treatment.
Does Dermagnify treat rosacea in Ponte Vedra Beach?
Yes. Dermagnify is a double board-certified dermatology practice in Ponte Vedra Beach, FL, offering Aerolase Neo laser treatment and comprehensive rosacea management under Dr. Mark A. Cappel, MD. We serve patients from across the greater Jacksonville area and northeastern Florida.